These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37611027)

  • 1. Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators.
    Wajda KE; Roesch EA; Gifford AH
    Curr Opin Pulm Med; 2023 Nov; 29(6):580-586. PubMed ID: 37611027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
    Mayer-Hamblett N; Ratjen F; Russell R; Donaldson SH; Riekert KA; Sawicki GS; Odem-Davis K; Young JK; Rosenbluth D; Taylor-Cousar JL; Goss CH; Retsch-Bogart G; Clancy JP; Genatossio A; O'Sullivan BP; Berlinski A; Millard SL; Omlor G; Wyatt CA; Moffett K; Nichols DP; Gifford AH;
    Lancet Respir Med; 2023 Apr; 11(4):329-340. PubMed ID: 36343646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007923. PubMed ID: 33686652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD007923. PubMed ID: 30480755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007923. PubMed ID: 27457496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007923. PubMed ID: 23737088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2011 May; (5):CD007923. PubMed ID: 21563162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis liver disease in the post-modulator era.
    Narkewicz MR
    Curr Opin Pulm Med; 2023 Nov; 29(6):621-625. PubMed ID: 37678151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise and Airway Clearance Techniques in Cystic Fibrosis.
    Ward N; Stiller K; Holland AE
    Semin Respir Crit Care Med; 2023 Apr; 44(2):209-216. PubMed ID: 36535668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators.
    Sathe M; Moshiree B; Aliaj E; Lee M; Hudson J; Gifford A; Attel S; Gamel B; Freedman SD; Schwarzenberg SJ; Freeman AJ
    Pediatr Pulmonol; 2023 Mar; 58(3):811-818. PubMed ID: 36448312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
    O'Carroll M
    Semin Respir Crit Care Med; 2023 Apr; 44(2):260-268. PubMed ID: 36893762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden.
    Goetz DM; Frederick CK; Perez G; Borowitz D
    Pediatr Pulmonol; 2023 Aug; 58(8):2375-2380. PubMed ID: 37232336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.